By Topic

Ligand discovery on massively parallel systems

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$33 $33
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

6 Author(s)
S. R. Shave ; Institute of Structural and Molecular Biology, School of Biological Sciences, University of Edinburgh, Michael Swann Building, King's Buildings, Mayfield Road, EH9 3JR, USA ; P. Taylor ; M. Walkinshaw ; L. Smith
more authors

Virtual screening is an approach for identifying promising leads for drugs and is used in the pharmaceutical industry. We present the parallelization of LIDAEUS (LIgand Discovery At Edinburgh UniverSity), creating a massively parallel high-throughput virtual-screening code. This program is being used to predict the binding modes involved in the docking of small ligands to proteins. Parallelization efforts have focused on achieving maximum parallel efficiency and developing a memory-efficient parallel sorting routine. Using an IBM Blue Gene/L™ supercomputer, runtimes have been reduced from 8 days on a modest seven-node cluster to 62 minutes on 1,024 processors using a standard dataset of 1.67 million small molecules and FKBP12, a protein target of interest in immunosuppressive therapies. Using more-complex datasets, the code scales upward to make use of the full processor set of 2,048. The code has been successfully used for the task of gathering data on approximately 1.67 million small molecules binding to approximately 400 high-quality crystallographically determined ligand-bound protein structures, generating data on more than 646 million protein-ligand complexes. A number of novel ligands have already been discovered and validated experimentally.

Note: The Institute of Electrical and Electronics Engineers, Incorporated is distributing this Article with permission of the International Business Machines Corporation (IBM) who is the exclusive owner. The recipient of this Article may not assign, sublicense, lease, rent or otherwise transfer, reproduce, prepare derivative works, publicly display or perform, or distribute the Article.  

Published in:

IBM Journal of Research and Development  (Volume:52 ,  Issue: 1.2 )